These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2981344)

  • 21. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I; Falk K; Minarovits J; Busson P; Tursz T; Masucci MG; Klein G
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.
    Grogan E; Jenson H; Countryman J; Heston L; Gradoville L; Miller G
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1332-6. PubMed ID: 3029778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA.
    Jenson HB; Rabson MS; Miller G
    J Virol; 1986 May; 58(2):475-86. PubMed ID: 3009861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
    Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated.
    Sample J; Henson EB; Sample C
    J Virol; 1992 Aug; 66(8):4654-61. PubMed ID: 1321268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus gene expression in interferon-treated cells. Implications for the regulation of protein synthesis and the antiviral state.
    Clarke PA; Sharp NA; Arrand JR; Clemens MJ
    Biochim Biophys Acta; 1990 Aug; 1050(1-3):167-73. PubMed ID: 2169891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Woisetschlaeger M; Yandava CN; Furmanski LA; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1725-9. PubMed ID: 2155423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
    Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
    J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes.
    Taylor KA; Wetzel S; Lyles DS; Pollok BA
    J Virol; 1994 Oct; 68(10):6421-31. PubMed ID: 8083980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
    Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
    J Virol; 2017 May; 91(9):. PubMed ID: 28228591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
    Kerr BM; Lear AL; Rowe M; Croom-Carter D; Young LS; Rookes SM; Gallimore PH; Rickinson AB
    Virology; 1992 Mar; 187(1):189-201. PubMed ID: 1310556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a cDNA clone corresponding to a transcript from the Epstein-Barr virus BamHI M fragment: evidence for overlapping mRNAs.
    Pfitzner AJ; Strominger JL; Speck SH
    J Virol; 1987 Sep; 61(9):2943-6. PubMed ID: 2441081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
    J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections.
    Heller M; van Santen V; Kieff E
    J Virol; 1982 Oct; 44(1):311-20. PubMed ID: 6292493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line.
    van Santen V; Cheung A; Kieff E
    Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1930-4. PubMed ID: 6112750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt lymphoma line during latency and after induction of viral replicative cycle by phorbol esters.
    Weigel R; Miller G
    Virology; 1983 Mar; 125(2):287-98. PubMed ID: 6301144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus.
    Frappier L; O'Donnell M
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10875-9. PubMed ID: 1660154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1.
    Prang N; Wolf H; Schwarzmann F
    J Med Virol; 1999 Dec; 59(4):512-9. PubMed ID: 10534735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
    Harrison S; Fisenne K; Hearing J
    J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.